Efficacy of entecavir treat patients with chronic hepatitis B and cirrhosis
Gang Zhong
Abstract
Gang Zhong
Abstract
Objective To investigate the effectacy of entecavir in the treatment of patients with chronic hepatitis B and cirrhosis.Methods We retrospectively analyzed 126 cases who had treat hepatitis B and cirrhosis in our department from September 2009 to February 2011.The 126 cases were randomly divided into 2 groups of 67 cases in the control group that were given treatment entecavir and 59 case in experimental that were given lamivudine.Contrast the convertion rate of HBV-DNA after 6 weeks,12 weeks,24 weeks,TBil,AST,ALT,Cllild-Pugh.Results ①The convertion rate of HBV-DNA after 6 weeks,12 weeks,24 weeks were significant differences of two groups(P0.05).②The level of TBil,HBV-DNA were significant differences of two groups(P0.05).③Child-Pugh were higher in the post-treatment than pretherapy in groups(P0.05)and were significant differences of two groups(P0.05).Conclusion Short term use entecavir is effective in treatment of patients with chronic hepatitis B and cirhosis.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the effectacy of entecavir in the treatment of patients with chronic hepatitis B and cirrhosis.Methods We retrospectively analyzed 126 cases who had treat hepatitis B and cirrhosis in our department from September 2009 to February 2011.The 126 cases were randomly divided into 2 groups of 67 cases in the control group that were given treatment entecavir and 59 case in experimental that were given lamivudine.Contrast the convertion rate of HBV-DNA after 6 weeks,12 weeks,24 weeks,TBil,AST,ALT,Cllild-Pugh.Results ①The convertion rate of HBV-DNA after 6 weeks,12 weeks,24 weeks were significant differences of two groups(P0.05).②The level of TBil,HBV-DNA were significant differences of two groups(P0.05).③Child-Pugh were higher in the post-treatment than pretherapy in groups(P0.05)and were significant differences of two groups(P0.05).Conclusion Short term use entecavir is effective in treatment of patients with chronic hepatitis B and cirhosis.
Key concepts: Entecavir, Medicine, Cirrhosis, Gastroenterology, Internal medicine, Lamivudine, Chronic hepatitis, Hepatitis B